Full Text View
Tabular View
Study Results
Related Studies
Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies
This study has been completed.
Study NCT00476229   Information provided by M.D. Anderson Cancer Center

First Received on May 17, 2007.   Last Updated on August 1, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma
Leukemia
Additional conditions recognized in this trial
Hematologic Neoplasms
Neoplasms
More general conditions related to this trial
Hematologic Diseases
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Neoplasms by Site
Interventions listed in this trial
Thymoglobulin
Total Lymphoid Irradiation
Peripheral Blood Stem Cell Infusion
Rituximab
Additional drug interventions recognized in this trial
Antilymphocyte Serum
More general drug interventions related to this trial
Antineoplastic Agents
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
Genzyme


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services